LifeVantage completes acquisition of microbiome company LoveBiome

Published 02/10/2025, 13:14
LifeVantage completes acquisition of microbiome company LoveBiome

SALT LAKE CITY - LifeVantage Corporation (NASDAQ:LFVN), a company currently trading at $9.56 and showing strong financial health according to InvestingPro analysis, announced Thursday it has completed its previously disclosed acquisition of LoveBiome, a direct sales company focused on microbiome care and wellness solutions.

The transaction includes LoveBiome’s core operating assets related to its microbiome health business and the retention of key personnel, according to a company press release.

"We are pleased to have closed the LoveBiome acquisition and look forward to working with Kelly Olsen and the LoveBiome team," said Steve Fife, President and CEO of LifeVantage.

The acquisition expands LifeVantage’s product portfolio into the gut health market while strengthening its presence in the United States, Taiwan, and Europe.

Kelly Olsen, founder and CEO of LoveBiome, stated that the partnership would allow the company to pursue its growth plans by combining LoveBiome’s P84 product with LifeVantage’s technologies and compensation structure.

LifeVantage, which describes itself as a pioneer in nutrigenomics, offers various health products including the Protandim family of supplements, TrueScience Liquid Collagen, and the MindBody GLP-1 System.

The financial terms of the acquisition were not disclosed in the announcement.

In other recent news, LifeVantage Corporation reported its fourth-quarter 2025 earnings, showcasing a positive surprise in earnings per share (EPS). The company announced an EPS of $0.17, surpassing analyst expectations of $0.16, representing a 6.25% surprise. However, the revenue figures did not meet projections, with the company reporting $55.1 million against a forecast of $56.88 million. Despite the revenue shortfall, the earnings announcement led to notable stock movement. These developments reflect the company’s recent financial performance. Investors and analysts are likely paying close attention to these figures. The earnings results are crucial for understanding the company’s financial health and future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.